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Sirs: Haemorrhagic stroke in
young patients is primarily caused
by elevated blood pressure, under-
lying vascular structural abnor-
malities, cardiac embolism or mi-
graine [1–3]. Vasculitis may be a
possible but uncommon aetiology
of ischemic stroke in patients aged
less than 45 years [4] and rarely
causes brain haemorrhage [5, 6].
We report on a patient who pre-
sented with haemorrhagic stroke
as the initial symptom of Wegener
granulomatosis (WG).
In March 2003, a 42 year old
male smoker presented with acute
onset of a right sensorimotor
hemisyndrome accompanied by
motor aphasia. Magnetic resonance
imaging (MRI) revealed a haemor-
rhagic stroke in the left basal gan-
glia, without underlying ischaemic
damage (Figure). No vascular mal-
formation, aneurysm, tumour or
venous thrombosis was observed.
Acutely, blood pressure was
180/90 mmHg but funduscopy as
well as urinary sediment did not
show signs of chronic hypertensive
damage. Cerebrovascular Doppler
ultrasound and transthoracic
echocardiography were negative.
Laboratory investigations showed
mild inflammatory signs and im-
munological tests revealed elevated
c-ANCA and anti PR-3 antibodies
(Table); p-ANCA, x-ANCA, anti
MPO antibodies, as well as CSF
analysis were negative. The patient
had no symptoms or signs charac-
teristic of WG: renal function, uri-
nary sediment, thorax radiography
and otorhinolaryngological exami-
nation were normal. Three months
later, the patient had no symptoms,
normal inflammatory parameters
and still elevated autoantibodies
(Table). In November 2003, he de-
veloped acute respiratory distress,
fever, oral ulcers, epistaxis and
arthralgia. Lung CT showed sub-
pleural nodules and infiltrates and
bronchoscopic bronchoalveolar
lavage revealed intraalveolar haem-
orrhage (30 % haemosidero-
phages). Microbiological analysis
for pneumocystis, nocardia, my-
coses, mycobacteries and CMV was
negative. Tongue and gingival
biopsy specimens showed non
specific ulcers. Glomerular micro-
haematuria (95 RBC/field) and
mild proteinuria (0.3 g/l proteins)
were now observed. Renal biopsy
revealed an impaired immunity
crescentic extracapillary glomeru-
lonephritis without granulomatous
lesions; c-ANCA and anti PR-3
antibodies elevation persisted and
inflammatory parameters had
reappeared (Table). Three out of
four ACR classification criteria [7]
were positive, so the diagnosis of
WG was established. The patient
was treated with intravenous
steroids and cyclophosphamide.
One month later, inflammatory
signs as well as autoantibodies nor-
malised and all systemic signs and
symptoms had resolved completely.
This patient presented with
haemorrhagic stroke; he did not
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Fig. T1 (left) and FLAIR (right) weighted brain MRI show predominantly hypointense lesion in the left lenticu-
lar nucleus (left) with a hyperintense oedematous ring surrounding the lesion (right)
Table Comparative evolution of autoantibodies levels, inflammatory parameters, and clinical features
March 2003 July 2003 November 2003 December 2003
Anti c-ANCA (n. r. < 1/20) 1/320* 1/320* 1/320* –
Anti PR3 (n. r. < 20 U) 73U* 67U* 75U* 21U
ESR (n. r. < 10 mm/h) 33 mm/h* 10 mm/h 40 mm/h* 18 mm/h
CRP (n. r. < 10 mg/l) 31 mg/l* < 2 mg/l 70 mg/l*
Symptoms Haemorrhagic None Fever, arthralgia, ENT, None
stroke lung, kidney disease
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have the clinical picture of WG,
but-ANCA and anti PR-3 antibod-
ies were significantly elevated and
a mild inflammatory syndrome
was present. Eight months later, he
developed specific symptoms and
signs of the disease without in-
volvement of the CNS. The imaging
studies excluded any vascular or
cardiac abnormality, and the pa-
tient had no objective signs of un-
derlying arterial hypertension or a
history of migraine. Therefore, we
believe that his haemorrhagic
stroke represented an unusual ini-
tial manifestation of WG.
WG is a primary small vessel
vasculitis. Its immunological hall-
mark is a diffuse cytoplasmic pat-
tern of antibodies (c-ANCA) that
are usually directed against pro-
teinase 3 (anti PR3) [13]. Concomi-
tant testing of c-ANCA and anti
PR3 antibodies can minimize false
positive results [14]. In our patients
both tests were consistently highly
positive and normalised only after
treatment. This case confirms that
WG may rarely be responsible for
cerebrovascular disease in young
adults [8–12] and that intracerebral
haematoma can exceptionally oc-
cur [8, 12]. Moreover, it illustrates
that WG may reveal itself exclu-
sively through neurological mani-
festations, without typical systemic
signs. In addition, though severe
CNS involvement has been de-
scribed in ANCA negative patients
[15], it suggests that autoantibodies
(c-ANCA/anti-PR3) represent a
valuable marker of WG even before
its clinical manifestation.
For all these reasons, we suggest
that WG should be considered as a
possible cause of haemorrhagic
stroke in a young patient in the ab-
sence of other causes. A positive c-
ANCA/PR-3 testing should lead to
a close clinical and paraclinical fol-
low up, in order to prevent a cata-
strophic outcome of this poten-
tially serious disease.
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